SAN FRANCISCO — The executives and investors who flew here from all over the world for the drug industry’s annual confab this week brought with them presentations, elevator pitches — and, well, lots of bugs. Especially on their smartphones.

That’s why Weill Cornell Medicine researchers are conducting a study at the J.P. Morgan Healthcare Conference to analyze the DNA of the microbes on attendees’ cell phones. They want to see whether cities leave a distinct microbial footprint on their residents’ iPhones.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Sign up for our biotech newsletter, The Readout

Get our guide to what's new in biotech delivered each morning.

Recommended Stories